These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16669979)

  • 21. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
    Nart A; Sipahi S; Aykas A; Uslu A; Hoşcoşkun C; Toz H
    Transplant Proc; 2008; 40(1):189-92. PubMed ID: 18261583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporine-induced renal impairment: a preliminary report.
    Papatheodoridis GV; O'Beirne J; Mistry P; Davidson B; Rolles K; Burroughs AK
    Transplantation; 1999 Jul; 68(1):155-7. PubMed ID: 10428285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation.
    Lyster H; Panicker G; Leaver N; Banner NR
    Transplant Proc; 2004 Dec; 36(10):3167-70. PubMed ID: 15686720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
    Tinawi M; Miller L; Bastani B
    Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
    Meier-Kriesche HU; Steffen BJ; Hochberg AM; Gordon RD; Liebman MN; Morris JA; Kaplan B
    Transplantation; 2003 Apr; 75(8):1341-6. PubMed ID: 12717227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
    Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
    Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New immunosuppressive treatment in kidney transplantation.
    Di Landro D; Sarzo G; Marchini F
    Clin Nephrol; 2000 Apr; 53(4):suppl 23-32. PubMed ID: 10809431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W
    Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation.
    Ostraat O; Qi Z; Olausson M; Tufveson G; Ekberg H
    Scand J Immunol; 1997 Apr; 45(4):343-8. PubMed ID: 9105419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T; Dubourg L; Saïd MH; Parchoux B; Ranchin B; Cochat P
    Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection.
    Zekry A; Gleeson M; Guney S; McCaughan GW
    Liver Transpl; 2004 Jan; 10(1):52-7. PubMed ID: 14755778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
    Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ
    J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.
    Wiesner R; Rabkin J; Klintmalm G; McDiarmid S; Langnas A; Punch J; McMaster P; Kalayoglu M; Levy G; Freeman R; Bismuth H; Neuhaus P; Mamelok R; Wang W
    Liver Transpl; 2001 May; 7(5):442-50. PubMed ID: 11349266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.
    Clayton PA; McDonald SP; Chapman JR; Chadban SJ
    Transplantation; 2012 Jul; 94(2):152-8. PubMed ID: 22728292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.
    Eisen HJ; Kobashigawa J; Keogh A; Bourge R; Renlund D; Mentzer R; Alderman E; Valantine H; Dureau G; Mancini D; Mamelok R; Gordon R; Wang W; Mehra M; Constanzo MR; Hummel M; Johnson J;
    J Heart Lung Transplant; 2005 May; 24(5):517-25. PubMed ID: 15896747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil severely depresses antibody response to CMV infection in early posttransplant period.
    Zmonarski SC; Boratynska M; Madziarska K; Klinger M; Kusztel M; Patrzalek D; Szyber P
    Transplant Proc; 2003 Sep; 35(6):2205-6. PubMed ID: 14529889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the calcineurin inhibitor of choice for pediatric renal transplantation?
    Kari JA; Trompeter RS
    Pediatr Transplant; 2004 Oct; 8(5):437-44. PubMed ID: 15367278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.
    El-Agroudy AE; El-Dahshan KF; Wafa EW; Sheashaa HA; Gad ZA; Ismail AM; Shokeir AA; Ghoneim MA
    Nephrology (Carlton); 2009 Apr; 14(2):255-61. PubMed ID: 19017277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.